Funding Opportunities

Engineering Solutions in Surgery

Designed to foster innovation and strengthen the collaborative efforts between faculty from Rice and BCM's Department of Surgery, this joint seed fund program focuses on advancing surgical research and education. The seed grants should lead to self-sustaining, nationally competitive research programs that will address critically important problems related to surgery. New call for proposals will be announced in April, 2025.

Awarded Projects

2024 -Two projects were selected for funding. More information.

"Parity-Time-Symmetric Wireless Transfer Systems to Eradicate Driveline Infections in Cardiac Assist Device."

"Structural Engineering of CeO₂/Perovskite Heterostructures for Tumor Imaging and Oxidative Stress Modulation via 3D-Printed Nanoneedle Patches Enabled Precision Delivery."


2023 - Two projects were selected for funding.

"Pathogenesis of Primary Graft Dysfunction in Lung Transplantation: Identifying Molecular and Cellular Biomarkers and Causal Effect of Sex."

  • Meng Li, PhD assistant professor of statistics, Rice University.
  • Gabriel Loor, MD associate professor, Michael E. DeBakey Department of Surgery, BCM.

"Systemic Biomarkers and Modern Multimodal Machine Learning Algorithms for Stroke Prediction in Heart Failure Patients with Mechanical Circulatory Support."


2021 - Three projects were selected for funding.

"Self-charging Wireless Pulse Sensor Integrated Vascular Graft for the Real-time Monitoring of Acute Thrombosis and Occlusion."

"Pathogenesis of Primary Graft Dysfunction in Lung Transplantation: Identifying Molecular and Cellular Biomarkers and Causal Effect of Sex."

  • Meng Li, PhD assistant professor of statistics, Rice University.
  • Gabriel Loor, MD associate professor, Michael E. DeBakey Department of Surgery, BCM.

"Detecting Human Performance Deficiencies in Surgical Simulation Training Using Intelligent Multi-Modal Sensors."


2018 -Three projects were selected for funding.

"Multifunctional 3D Printed Biomesh for Surgical Hernia Repair."

"Gene delivery of reprogramming factors to injured hearts to improve cardiac function."

"Sustained local IL2 “Living Drug Therapy” enhances virus-like particles vaccine efficacy in controlling pancreatic cancer in preclinical animal models."